Study to Evaluate the Safety, Tolerability, and Efficacy of Long-term Adjunctive Therapy With Lacosamide in Adults With Partial-onset Seizures

NCT01832038 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

473

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy
Partial-onset Seizures

Interventions

DRUG: Lacosamide

Sponsor

UCB Pharma SA

Collaborators

[object Object]